Literature DB >> 35397175

Estrogen receptors observed at extranuclear neuronal sites and in glia in the nucleus accumbens core and shell of the female rat: Evidence for localization to catecholaminergic and GABAergic neurons.

Anne Almey1, Teresa A Milner2,3, Wayne G Brake1.   

Abstract

Estrogens affect dopamine-dependent diseases/behavior and have rapid effects on dopamine release and receptor availability in the nucleus accumbens (NAc). Low levels of nuclear estrogen receptor (ER) α and ERβ are seen in the NAc, which cannot account for the rapid effects of estrogens in this region. G-protein coupled ER 1 (GPER1) is observed at low levels in the NAc shell, which also likely does not account for the array of estrogens' effects in this region. Prior studies demonstrated membrane-associated ERs in the dorsal striatum; these experiments extend those findings to the NAc core and shell. Single- and dual-immunolabeling electron microscopy determined whether ERα, ERβ, and GPER1 are at extranuclear sites in the NAc core and shell and whether ERα and GPER1 were localized to catecholaminergic or γ-aminobutyric acid-ergic (GABAergic) neurons. All three ERs are observed, almost exclusively, at extranuclear sites in the NAc, and similarly distributed in the core and shell. ERα, ERβ, and GPER1 are primarily in axons and axon terminals suggesting that estrogens affect transmission in the NAc via presynaptic mechanisms. About 10% of these receptors are found on glia. A small proportion of ERα and GPER1 are localized to catecholaminergic terminals, suggesting that binding at these ERs alters release of catecholamines, including dopamine. A larger proportion of ERα and GPER1 are localized to GABAergic dendrites and terminals, suggesting that estrogens alter GABAergic transmission to indirectly affect dopamine transmission in the NAc. Thus, the localization of ERs could account for the rapid effects of estrogen in the NAc.
© 2022 Wiley Periodicals LLC.

Entities:  

Keywords:  G-protein coupled estrogen receptor 1; electron microscopy; estrogen receptor alpha; estrogen receptor beta; ventral striatum; γ-aminobutyric acid

Mesh:

Substances:

Year:  2022        PMID: 35397175      PMCID: PMC9167786          DOI: 10.1002/cne.25320

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.028


  85 in total

1.  ERbeta mediates the estradiol increase of D2 receptors in rat striatum and nucleus accumbens.

Authors:  Maryvonne Le Saux; Marc Morissette; Thérèse Di Paolo
Journal:  Neuropharmacology       Date:  2005-11-23       Impact factor: 5.250

Review 2.  Rapid effects of ovarian hormones in dorsal striatum and nucleus accumbens.

Authors:  Katie E Yoest; Jacqueline A Quigley; Jill B Becker
Journal:  Horm Behav       Date:  2018-04-22       Impact factor: 3.587

Review 3.  Role of estrogen treatment in the management of schizophrenia.

Authors:  Jayashri Kulkarni; Emmy Gavrilidis; Roisin Worsley; Emily Hayes
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

4.  Distribution of estrogen receptor beta immunoreactivity in the rat central nervous system.

Authors:  P J Shughrue; I Merchenthaler
Journal:  J Comp Neurol       Date:  2001-07-16       Impact factor: 3.215

5.  Alternation behavior, spatial discrimination, and reversal disturbances following 6-hydroxydopamine lesions in the nucleus accumbens of the rat.

Authors:  K Taghzouti; A Louilot; J P Herman; M Le Moal; H Simon
Journal:  Behav Neural Biol       Date:  1985-11

Review 6.  Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration.

Authors:  Rory D Spence; Rhonda R Voskuhl
Journal:  Front Neuroendocrinol       Date:  2011-12-24       Impact factor: 8.606

7.  Differential and synergistic roles of 17β-estradiol and progesterone in modulating adult female rat nucleus accumbens core medium spiny neuron electrophysiology.

Authors:  Stephanie B Proaño; Amanda A Krentzel; John Meitzen
Journal:  J Neurophysiol       Date:  2020-05-13       Impact factor: 2.714

8.  Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues.

Authors:  Georgina G J Hazell; Song T Yao; James A Roper; Eric R Prossnitz; Anne-Marie O'Carroll; Stephen J Lolait
Journal:  J Endocrinol       Date:  2009-05-06       Impact factor: 4.286

Review 9.  Repurposing sex steroids and related drugs as potential treatment for Parkinson's disease.

Authors:  Mélanie Bourque; Marc Morissette; Thérèse Di Paolo
Journal:  Neuropharmacology       Date:  2018-04-09       Impact factor: 5.250

10.  Estrogen receptor alpha, G-protein coupled estrogen receptor 1, and aromatase: Developmental, sex, and region-specific differences across the rat caudate-putamen, nucleus accumbens core and shell.

Authors:  Amanda A Krentzel; Jaime A Willett; Ashlyn G Johnson; John Meitzen
Journal:  J Comp Neurol       Date:  2020-08-03       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.